Azura Ophthalmics

Azura Ophthalmics

Developing an innovative portfolio of compounds to advance treatments for Meibomian gland dysfunction , the leading cause of Dry Eye Disease.

HQ location
Tel Aviv-Yafo, Israel
Launch date
Employees
Enterprise value
$80—120m
Company register number
515003747
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads